Frontiers in Immunology (Feb 2022)
Sustained Antibody-Dependent NK Cell Functions in Mild COVID-19 Outpatients During Convalescence
- Francisco Fuentes-Villalobos,
- Jose L. Garrido,
- Jose L. Garrido,
- Matías A. Medina,
- Nicole Zambrano,
- Natalia Ross,
- Felipe Bravo,
- Aracelly Gaete-Argel,
- Aarón Oyarzún-Arrau,
- Fatima Amanat,
- Ricardo Soto-Rifo,
- Fernando Valiente-Echeverría,
- Renato Ocampo,
- Christian Esveile,
- Leonila Ferreira,
- Johanna Cabrera,
- Vivianne Torres,
- Maria L. Rioseco,
- Maria L. Rioseco,
- Raúl Riquelme,
- Raúl Riquelme,
- Sebastián Barría,
- Raymond Alvarez,
- Raymond Alvarez,
- Yazmín Pinos,
- Florian Krammer,
- Mario Calvo,
- Maria I. Barria,
- Maria I. Barria,
- COVID-19 South Chile Group
Affiliations
- Francisco Fuentes-Villalobos
- Department of Microbiology, Faculty of Biological Science, Universidad de Concepción, Concepción, Chile
- Jose L. Garrido
- Ichor Biologics LLC, New York, NY, United States
- Jose L. Garrido
- Facultad de Medicina y Ciencia, Universidad San Sebastián, Puerto Montt, Chile
- Matías A. Medina
- Department of Microbiology, Faculty of Biological Science, Universidad de Concepción, Concepción, Chile
- Nicole Zambrano
- Department of Microbiology, Faculty of Biological Science, Universidad de Concepción, Concepción, Chile
- Natalia Ross
- Department of Microbiology, Faculty of Biological Science, Universidad de Concepción, Concepción, Chile
- Felipe Bravo
- Department of Microbiology, Faculty of Biological Science, Universidad de Concepción, Concepción, Chile
- Aracelly Gaete-Argel
- Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile
- Aarón Oyarzún-Arrau
- Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile
- Fatima Amanat
- Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States
- Ricardo Soto-Rifo
- Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile
- Fernando Valiente-Echeverría
- Laboratory of Molecular and Cellular Virology, Virology Program, Institute of Biomedical Sciences, Faculty of Medicine, Universidad de Chile, Santiago, Chile
- Renato Ocampo
- Hospital Regional de Talca, Talca, Chile
- Christian Esveile
- Hospital Clínico Herminda Martin, Chillán, Chile
- Leonila Ferreira
- Hospital Clínico Regional Dr. Guillermo Grant Benavente, Concepción, Chile
- Johanna Cabrera
- Hospital Dr. Hernán Henríquez Aravena, Temuco, Chile
- Vivianne Torres
- 0Institute of Medicine, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Chile
- Maria L. Rioseco
- Facultad de Medicina y Ciencia, Universidad San Sebastián, Puerto Montt, Chile
- Maria L. Rioseco
- 1Hospital Puerto Montt Dr. Eduardo Schütz Schroeder, Puerto Montt, Chile
- Raúl Riquelme
- Facultad de Medicina y Ciencia, Universidad San Sebastián, Puerto Montt, Chile
- Raúl Riquelme
- 1Hospital Puerto Montt Dr. Eduardo Schütz Schroeder, Puerto Montt, Chile
- Sebastián Barría
- 1Hospital Puerto Montt Dr. Eduardo Schütz Schroeder, Puerto Montt, Chile
- Raymond Alvarez
- Ichor Biologics LLC, New York, NY, United States
- Raymond Alvarez
- 2Division of Infectious Diseases, Department of Medicine, Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States
- Yazmín Pinos
- 3Hospital Base San José, Osorno, Chile
- Florian Krammer
- Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, United States
- Mario Calvo
- 0Institute of Medicine, Faculty of Medicine, Universidad Austral de Chile, Valdivia, Chile
- Maria I. Barria
- Department of Microbiology, Faculty of Biological Science, Universidad de Concepción, Concepción, Chile
- Maria I. Barria
- Facultad de Medicina y Ciencia, Universidad San Sebastián, Puerto Montt, Chile
- COVID-19 South Chile Group
- DOI
- https://doi.org/10.3389/fimmu.2022.796481
- Journal volume & issue
-
Vol. 13
Abstract
The coronavirus disease 2019 (COVID19) pandemic has left researchers scrambling to identify the humoral immune correlates of protection from COVID-19. To date, the antibody mediated correlates of virus neutralization have been extensively studied. However, the extent that non-neutralizing functions contribute to anti-viral responses are ill defined. In this study, we profiled the anti-spike antibody subtype/subclass responses, along with neutralization and antibody-dependent natural killer cell functions in 83 blood samples collected between 4 and 201 days post-symptoms onset from a cohort of COVID-19 outpatients. We observed heterogeneous humoral responses against the acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein. Overall, anti-spike profiles were characterized by a rapid rise of IgA and sustained IgG titers. In addition, strong antibody-mediated natural killer effector responses correlated with milder disease and being female. While higher neutralization profiles were observed in males along with increased severity. These results give an insight into the underlying function of antibodies beyond neutralization and suggest that antibody-mediated natural killer cell activity is a key function of the humoral response against the SARS-CoV-2 spike protein.
Keywords